Pullen Investment Management, LLC Hcw Biologics Inc. Transaction History
Pullen Investment Management, LLC
- $137 Billion
- Q3 2024
A detailed history of Pullen Investment Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Pullen Investment Management, LLC holds 75,116 shares of HCWB stock, worth $30,797. This represents 0.03% of its overall portfolio holdings.
Number of Shares
75,116
Previous 85,116
11.75%
Holding current value
$30,797
Previous $55.1 Million
26.42%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding HCWB
# of Institutions
17Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$114,6110.01% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$75,1360.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$74,1320.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$54,1150.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX84.7KShares$34,7270.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.7M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...